Explore facts and recommendations for pharmacological treatments for hemoglobinopathies.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
HbF Induction
The Role of PKR Activation in Sickle Cell Disease
Sickle Cell Disease Clinical Development Programs
Information about various clinical trials (ASCENT1, HIBISCUS, GLADIOLUS, etc) to evaluate safety and efficacy for sickle cell disease and/or other hemoglobinopathies.
Find more information
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Continuing education
Learn about accredited hemoglobinopathies education opportunities supported by Novo Nordisk and provided by third-party organizations.